Dana-Farber Cancer Institute - Medicine is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.
Dana-Farber Cancer Institute - Medicine has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Renal Cell Carcinoma, Non-small Cell Lung Cancer, Melanoma.
Sponsors: AVEO Pharmaceuticals, Inc., iOx Therapeutics.
Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Cancer Institute - Medicine has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Cancer Institute - Medicine has 2 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma, Non-small Cell Lung Cancer, Melanoma.
Dana-Farber Cancer Institute - Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.